bilaterals.org logo
bilaterals.org logo

medicines


The Pacific free trade deal that’s anything but free
Just Foreign Policy is offering a reward, now up to $21,100, to WikiLeaks if it publishes a draft copy of the TPP. People could add to the reward fund, or if in a position to do so, make a copy of the draft agreement available to the world.
Malaysia says no to TPP
Malaysian Health Minister Datuk Seri Liow Tiong Lai said the Trans-Pacific Partnership Agreement, which is being negotiated among eleven countries including the US and Malaysia, would be detrimental to the local medical industry.
Protesters: Free trade deals, drug patents derail AIDS fight
As the nineteenth International AIDS Conference continued in Washington Tuesday, thousands of protesters marched on the White House calling for an end to free trade deals that protesters argue make vital AIDS medicines unaffordable.
Access to medicines and intellectual property in Jordan
Delayed market entry of generics due to enhanced intellectual property protection cost Jordanian private consumers approximately 18 million US dollars annually
Mulroney wades into EU free-trade talks, egging on pharma
Former Canadian Prime Minister Brian Mulroney is wading into the high-stakes debate over patent protection in the free trade talks with Europe, and he’s clearly taking sides.
Provinces join forces to keep EU free-trade deal from upping drug costs
The provincial premiers have undertaken a letter-writing campaign to demand compensation from the federal government for any increase in drug costs that might results from a free-trade agreement with Europe.
Canada’s other drug war
There’s a debate raging over Canada’s intellectual property regime. If one side’s right, Canada stands to pay $2.8 billion more every year in drug costs while it undermines its generic-drug manufacturing sector.
After KORUS FTA, new pressures on the horizon
As the South Korea-United States Free Trade Agreement (KORUS FTA) takes effects Thursday, some are expecting new trade pressures from the US, including moves to open the beef market. In particular, South Korea will be forced to sit down at the negotiating table if the US requests negotiations on beef.
US calls for additional FTA measures to ensure transparency in medicine pricing in Korea
With just days left before the implementation of the US-Korea free trade agreement Washington is drawing attention to a little publicized area of the trade treaty, the part covering the pricing of medicine in Korea. The US says it wants more transparency; the Korean pharmaceutical industry says it wants to maintain control over pricing domestically.
TPP negotiators turn to pharmaceutical reimbursement
Negotiations of the Transpacific Partnership Agreement (TPP) have turned to discussions of the pharmaceutical reimbursement chapter. This issue is highly controversial and represents a very recent shift in US trade policy.
Does EU/India free trade agreement spell the end of cheap drugs for poor countries?
After four years of negotiations, campaigners fear India is about to sign a trade deal with the EU which will stop the flow of cheap life-saving drugs to the developing world
Act Up-Paris confront Karel De Gucht on ACTA and EU-India FTA
Supporting the ongoing Global Week of Action on the EU-India FTA, Pauline Londeix of Act Up-Paris today confronted the European Commission for Trade, Karel de Gucht at a “Civil Society dialogue on Trade, Growth and development” at the European Commission. De Gucht reportedly leaves for India tomorrow for the EU-India Summit on 10th February 2012 where the E.C. is putting pressure on the Indian government to announce political trade-offs in the EU-India FTA.
Network calls for rejection of free trade agreement
Fiji Network for Positive People believes that the Asia Pacific Network of People Living with HIV/AIDS meeting will be an opportune time to advocate for continuing availability of generic Anti Retro Viral treatment in the face of threats from Free Trade Agreement negotiations.
AMCHAM interferes in domestic policies through FTA
Under the Korea-US Free Trade Agreement (KORUS FTA), Korean civil servants would be excluded from the Health Insurance Review and Assessment Service (HIRA)’s process of price determination. Instead independent review procedures could be used to set prices for medicines and medical supplies. This has caused concern among health care groups who worry that multinational pharmaceutical companies could use the independent review procedure to change the Korean government’s medicine prices.
NGO asks European Commission not to push India to accept IP provisions in EU-India FTA
As the 14th round of negotiations on the EU-India free trade agreement is held in Delhi, an NGO working in the health sector has urged the European Union not to push India to accept IP provisions in the deal
EU-India FTA negotiations: DNP+ protest
DNP+ believes that IP should be completely be removed from the trade negotiations.
Legal scholars release critical analysis of US proposals for IP and pharmaceutical chapters of the TPP
The scholars’ analysis concludes that the "US proposals, if adopted, would upset the current international framework balancing the minimum standards for exclusive rights for media and technology owners, on the one hand, and the access rights of the public, competitors, innovators and creators, on the other."
TPP - US TBT proposal (2011)
Citizen Trade Campaign has released this proposed text from the US on technical barriers to trade relating to medical devices and pharmaceuticals under the Trans Pacific Partnership
Indian pharma industry to gain from free trade agreement with Gulf nations
The Indian pharmaceuticals and chemicals industry will be among the biggest beneficiaries of a free trade agreement between the GCC and India, a leading banker in the region has said.
US seeks to allay drug access concerns in TPP talks
The Obama administration on Monday sought to allay concerns that the U.S. push for stronger drug patent protections in a Transpacific trade deal would raise the cost of life-saving treatments out of the reach of the region’s poor people.